• Tuesday, Sep 29, 2020
  • Last Update : 08:16 pm

UK signs up for Sanofi-GSK coronavirus vaccine

  • Published at 06:12 pm July 29th, 2020
WEB_Vaccine
File photo: A woman holds a small bottle labeled with a "Vaccine Covid-19"sticker and a medical syringe in this illustration taken April 10, 2020 Reuters

Sanofi predicted regulatory approval for the vaccine 'could be achieved by the first half of 2021'

Pharma giants Sanofi and GSK said Wednesday they have agreed to supply Britain with up to 60 million doses of a potential Covid-19 vaccine.

The agreement covers a vaccine candidate developed by France's Sanofi in partnership with the UK's GSK and is subject to a "final contract."

Amid a global race to find a vaccine to halt the pandemic, Sanofi announced "ongoing discussions with the European Commission, with France and Italy on the negotiation team, and other governments to ensure global access to a novel coronavirus vaccine."

Both companies voiced in a statement their commitment "to making their Covid-19 vaccine candidate affordable and available globally."

The vaccine candidate "has the potential to play a significant role in overcoming the Covid-19 pandemic, both in the UK and around the world," said GSK Vaccines President Roger Connor.

Sanofi predicted regulatory approval for the vaccine "could be achieved by the first half of 2021."

UK Business Secretary Alok Sharma, quoted in the statement, hailed the progress but noted "the fact remains that there are no guarantees."

“In the meantime, it is important that we secure early access to a diverse range of promising vaccine candidates, like GSK and Sanofi, to increase our chances of finding one that works so we can protect the public and save lives."

Britain has already secured access to 90 million doses of potential coronavirus vaccines in deals with biotech firms BioNTech, Pfizer and Valneva.

The deals involve 30 million doses of a vaccine being developed by US pharma giant Pfizer and Germany's BioNTech, and 60 million doses of another created by France's Valneva.

The government in London has also said it would purchase 100 million doses of a vaccine currently being trialed by Oxford University in partnership with AstraZeneca.

"This diversity of vaccine types is important because we do not yet know which, if any, of the different types of vaccine will prove to generate a safe and protective response to Covid-19," Kate Bingham, chairwoman of the British government's vaccine taskforce, was quoted as saying.

Britain has been one of the worst affected countries in the world since the outbreak began, with more than 45,750 deaths.

51
51
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail